1. Home
  2. CRNX vs SXI Comparison

CRNX vs SXI Comparison

Compare CRNX & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • SXI
  • Stock Information
  • Founded
  • CRNX 2008
  • SXI 1955
  • Country
  • CRNX United States
  • SXI United States
  • Employees
  • CRNX N/A
  • SXI N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • SXI Industrial Machinery/Components
  • Sector
  • CRNX Health Care
  • SXI Industrials
  • Exchange
  • CRNX Nasdaq
  • SXI Nasdaq
  • Market Cap
  • CRNX 2.8B
  • SXI 2.3B
  • IPO Year
  • CRNX 2018
  • SXI N/A
  • Fundamental
  • Price
  • CRNX $30.40
  • SXI $211.02
  • Analyst Decision
  • CRNX Strong Buy
  • SXI Strong Buy
  • Analyst Count
  • CRNX 7
  • SXI 4
  • Target Price
  • CRNX $74.33
  • SXI $223.50
  • AVG Volume (30 Days)
  • CRNX 1.0M
  • SXI 136.2K
  • Earning Date
  • CRNX 08-07-2025
  • SXI 07-31-2025
  • Dividend Yield
  • CRNX N/A
  • SXI 0.61%
  • EPS Growth
  • CRNX N/A
  • SXI N/A
  • EPS
  • CRNX N/A
  • SXI 4.64
  • Revenue
  • CRNX $1,392,000.00
  • SXI $790,107,000.00
  • Revenue This Year
  • CRNX $489.51
  • SXI $14.61
  • Revenue Next Year
  • CRNX $661.93
  • SXI $7.59
  • P/E Ratio
  • CRNX N/A
  • SXI $45.49
  • Revenue Growth
  • CRNX 0.51
  • SXI 9.64
  • 52 Week Low
  • CRNX $24.10
  • SXI $128.85
  • 52 Week High
  • CRNX $62.53
  • SXI $212.66
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 53.04
  • SXI 73.41
  • Support Level
  • CRNX $28.73
  • SXI $198.47
  • Resistance Level
  • CRNX $31.70
  • SXI $212.42
  • Average True Range (ATR)
  • CRNX 1.29
  • SXI 5.61
  • MACD
  • CRNX 0.25
  • SXI 0.26
  • Stochastic Oscillator
  • CRNX 77.85
  • SXI 94.87

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About SXI Standex International Corporation

Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. The company has five reportable segments: Electronics, Engraving, Scientific, Engineering Technologies, and Specialty Solutions. The maximum revenue is generated from its Electronics segment, which is a component and value-added services provider of both sensing and switching technologies, as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging, among others. Geographically, it derives key revenue from the United States and the rest from the Asia Pacific, Europe, the Middle East, and Africa (EMEA), as well as other regions.

Share on Social Networks: